Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that about 30,000 patients [1] have been treated using Merck Serono's growth hormone injection device, easypod™ since its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback